Inflammation in atherosclerosis: A new therapeutic target

Pharmacology, Toxicology and Pharmaceutical Science

• Peroxisome Proliferator Activated Receptor 100%
• Immunoglobulin Enhancer Binding Protein 100%
• Atherosclerosis 100%
• Inflammation 100%
• Coronary Artery Disease 66%
• Antiviral Therapy 33%
• Antiinflammatory Activity 33%
• Antibacterial Therapy 33%
• Salicylic Acid Derivative 33%
• Inflammatory Disease 33%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 33%
• Acetylsalicylic Acid 33%
• Fibric Acid Derivative 33%
• Dipeptidyl Carboxypeptidase Inhibitor 33%
• Angiotensin Receptor Antagonist 33%
• Disorders of Lipid Metabolism 33%
• Insulin Sensitizing Agent 33%
• Transcription Factors 33%
• Diseases 33%

Medicine and Dentistry

• Immunoglobulin Enhancer Binding Protein 100%
• Atherosclerosis 100%
• Peroxisome Proliferator Activated Receptor 100%
• Coronary Artery Disease 66%
• Serositis 33%
• Antiinflammatory Activity 33%
• Lipid Storage 33%
• Disease Process 33%
• ACE Inhibitor 33%
• Antiviral Therapy 33%
• Acetylsalicylic Acid 33%
• Antibiotic Therapy 33%
• Insulin Sensitizing Agent 33%
• Disorders of Lipid Metabolism 33%
• Angiotensin Receptor Antagonist 33%
• Pathological Process 33%
• Statin 33%
• Inflammatory Disorder 33%
• Salicylic Acid Derivative 33%
• Transcription Factors 33%